Terms: = Breast cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Treatment
43 results:
1. Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy.
Cen Y; Chen Y; Li X; Chen X; Yu B; Yan M; Yan N; Cheng H; Li S
Biomaterials; 2024 Jul; 308():122568. PubMed ID: 38615488
[TBL] [Abstract] [Full Text] [Related]
2. rel-A/PACER/miR 7 Axis May Play a Role in Radiotherapy treatment in breast cancer Patients.
Fazlollah S; Hossein M; Mir Davood O
Iran Biomed J; 2023 Jul; 27(4):173-82. PubMed ID: 37507347
[TBL] [Abstract] [Full Text] [Related]
3. GSH resistant, luminescent 2-(pyren-1-yl)-1
Das R; Paira P
Dalton Trans; 2023 Oct; 52(42):15365-15376. PubMed ID: 37493615
[TBL] [Abstract] [Full Text] [Related]
4. Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics.
Zubair M; Khalil S; Rasul I; Nadeem H; Noor F; Ahmad S; Alrumaihi F; Allemailem KS; Almatroudi A; Alshehri FF; Alshehri ZS
J Biomol Struct Dyn; 2023; 41(24):14715-14729. PubMed ID: 37301608
[TBL] [Abstract] [Full Text] [Related]
5. Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1.
Huang M; O'Shaughnessy J; Haiderali A; Pan W; Hu P; Chaudhuri M; Le Bailly De Tilleghem C; Cappoen N; Fasching PA
Eur J Cancer; 2022 Dec; 177():45-52. PubMed ID: 36323052
[TBL] [Abstract] [Full Text] [Related]
6. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.
Zhang M; Liu ZZ; Aoshima K; Cai WL; Sun H; Xu T; Zhang Y; An Y; Chen JF; Chan LH; Aoshima A; Lang SM; Tang Z; Che X; Li Y; Rutter SJ; Bossuyt V; Chen X; Morrow JS; Pusztai L; Rimm DL; Yin M; Yan Q
Sci Transl Med; 2022 Feb; 14(630):eabf5473. PubMed ID: 35108062
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA‑188‑5p inhibits the progression of breast cancer by targeting zinc finger protein 91.
Yang Z; Liu Z; Chang Z; Yan G
Oncol Rep; 2020 Oct; 44(4):1479-1488. PubMed ID: 32945499
[TBL] [Abstract] [Full Text] [Related]
8. breast cancer Cell Detection and Characterization from breast Milk-Derived Cells.
Bhat-Nakshatri P; Kumar B; Simpson E; Ludwig KK; Cox ML; Gao H; Liu Y; Nakshatri H
Cancer Res; 2020 Nov; 80(21):4828-4839. PubMed ID: 32934021
[TBL] [Abstract] [Full Text] [Related]
9. Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy.
Dieckmeyer M; Ruschke S; Rohrmeier A; Syväri J; Einspieler I; Seifert-Klauss V; Schmidmayr M; Metz S; Kirschke JS; Rummeny EJ; Zimmer C; Karampinos DC; Baum T
BMC Musculoskelet Disord; 2019 Nov; 20(1):515. PubMed ID: 31694630
[TBL] [Abstract] [Full Text] [Related]
10. Early Decline in Left Ventricular Ejection Fraction Can Predict Trastuzumab-related Cardiotoxicity in Patients with breast cancer: A Study Using 13 Years of Registry Data.
Kim EK; Cho J; Kim JY; Chang SA; Park SJ; Choi JO; Lee SC; Ahn JS; Park SW; Im YH; Jeon ES; Park YH
Cancer Res Treat; 2019 Apr; 51(2):727-736. PubMed ID: 30177584
[TBL] [Abstract] [Full Text] [Related]
11. Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic breast cancer: A Q-TWiST Analysis.
Cortes J; Pérez-García J; Whiting S; Wan Y; Solem C; Tai MH; Margunato-Debay S; Ko A; Fandi A; Botteman M
Clin Breast Cancer; 2018 Oct; 18(5):e919-e926. PubMed ID: 29703690
[TBL] [Abstract] [Full Text] [Related]
12. The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment.
Kim JY; Jung HH; Ahn S; Bae S; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Aug; 6():31804. PubMed ID: 27545642
[TBL] [Abstract] [Full Text] [Related]
13. Anti-Inflammatory Effects of a Methanol Extract from the Marine Sponge Geodia cydonium on the Human breast cancer MCF-7 Cell Line.
Costantini S; Romano G; Rusolo F; Capone F; Guerriero E; Colonna G; Ianora A; Ciliberto G; Costantini M
Mediators Inflamm; 2015; 2015():204975. PubMed ID: 26491222
[TBL] [Abstract] [Full Text] [Related]
14. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
[TBL] [Abstract] [Full Text] [Related]
15. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract] [Full Text] [Related]
16. Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.
Emery SM; Alotaibi MR; Tao Q; Selley DE; Lichtman AH; Gewirtz DA
J Pharmacol Exp Ther; 2014 Feb; 348(2):293-302. PubMed ID: 24259678
[TBL] [Abstract] [Full Text] [Related]
17. The role of chemoradiotherapy in patients with unresectable T4 breast tumors.
Karasawa K; Saito M; Hirowatari H; Izawa H; Furuya T; Ozawa S; Ito K; Suzuki T; Mitsuhashi N
Breast Cancer; 2013 Jul; 20(3):254-61. PubMed ID: 22274798
[TBL] [Abstract] [Full Text] [Related]
18. Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics.
Antoni MH; Lutgendorf SK; Blomberg B; Carver CS; Lechner S; Diaz A; Stagl J; Arevalo JM; Cole SW
Biol Psychiatry; 2012 Feb; 71(4):366-72. PubMed ID: 22088795
[TBL] [Abstract] [Full Text] [Related]
19. Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib.
Sherrill B; Sherif B; Amonkar MM; Maltzman J; O'Rourke L; Johnston S
Curr Med Res Opin; 2011 Dec; 27(12):2245-52. PubMed ID: 21992075
[TBL] [Abstract] [Full Text] [Related]
20. Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer.
Corey-Lisle PK; Peck R; Mukhopadhyay P; Orsini L; Safikhani S; Bell JA; Hortobagyi G; Roche H; Conte P; Revicki DA
Cancer; 2012 Jan; 118(2):461-8. PubMed ID: 21598243
[TBL] [Abstract] [Full Text] [Related]
[Next]
